News und Analysen
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Reports Solid Performance and Reiterates Break-even Target for FY 2023/2024 despite a Challenging Market Environment
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Reports Solid Performance and Reiterates Break-even Target for FY 2023/2024 despite a Challenging Market Environment
EQS-News: Instone Real Estate Group SE: Instone starts the year well despite persistently difficult environment
EQS-News: Instone Real Estate Group SE: Instone starts the year well despite persistently difficult environment
EQS-News: SYNLAB AG: SYNLAB reports strong start to fiscal year 2023
EQS-News: SYNLAB AG: SYNLAB reports strong start to fiscal year 2023
EQS-News: SYNLAB AG: SYNLAB invests in new, cutting-edge laboratory in Munich and further expands its leading position in the region
EQS-News: SYNLAB AG: SYNLAB invests in new, cutting-edge laboratory in Munich and further expands its leading position in the region
EQS-Adhoc: New Work SE: New Work SE reduces forecast for pro forma EBITDA and pro forma revenue growth
EQS-Adhoc: New Work SE: New Work SE reduces forecast for pro forma EBITDA and pro forma revenue growth
EQS-News: Instone Real Estate Group SE announces CFO change
EQS-News: Instone Real Estate Group SE announces CFO change
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma